|
CARI-Australia |
|
|
|
| CSN-Canada |
|
|
|
EBPG-Europe
2002 |
• LDL-cholesterol
<100 mg/dL (2.6 mmol/L)
• Triglycerides < 180 mg/dl (2.0 mmol/L)
• Non-HDL cholesterol < 130 mg/dl (3.36 mmol/l) |
Guideline VII.2 Dyslipidaemia
p 5-7 of 8 website PDF pages
|
Evidence level C
Evidence level C
Evidence level C
• Blood collections in fasting state
• Measurements every 6 weeks during initiation intervention
• Measurements every 4-6 months in steady state
• Not after surgery or during acute conditions |
KDOQI-US
2003 |
• LDL-cholesterol <100 mg/dl (2.6 mmol/L)
• Triglycerides < 200 mg/dl (2.26 mmol/L)
• Non-HDL cholesterol < 130 mg/dl (3.36 mmol/l) |
Guideline 4. Treatment of adults with dyslipidemias
|
Evidence level B and C |
UK-Guidelines
2002 |
• Total
cholesterol < 195 mg/dl (5 mmol/L) or 30% reduction from
baseline
• Total cholesterol < 195 mg/dl (5 mmol/L) or 30% reduction
from baseline, or LDL-cholesterol < 115 mg/dl (3 mmol/L) |
Chapter 6: Cardiovascular risk factors in patients
on dialysis. Page 111 of 204 pdf. |
Evidence
level C |
